We have earlier described mexA-mexB-oprK, an operon involved in pyoverdine export in Pseudomonas aeruginosa, and suggested that the products of these genes also contribute to the active efflux of several antibiotics (K. Poole, K. Krebes, C. McNally, and S. Neshat, J. Bacteriol. 175:7363-7372, 1993). Recently the outer membrane component of this efflux system was shown to be OprM, rather than OprK (N. Gotoh and K. Poole, unpublished results). In the present study, the conclusion concerning the efflux activity of this system was confirmed and extended by the measurement of drug accumulation in intact cells. Thus, the steady-state accumulation levels of tetracycline and norfloxacin were increased in mexA and oprM null mutants. mexA and oprM null mutants also showed an increase in susceptibility to a wide variety of ␤-lactam antibiotics and an increase in the steady-state accumulation level of benzylpenicillin, indicating that the MexA-MexB-OprM pump also effluxes ␤-lactams. Furthermore, deenergization of the cytoplasmic membrane with a proton conductor always produced a strong increase in the accumulation level. Finally, a single-step mutant overproducing MexAB-OprM accumulated less tetracycline and chloramphenicol than the parent strain and was more resistant to a wide range of antimicrobial compounds, including ␤-lactams. These results support the notion that these proteins contribute to the intrinsic resistance of P. aeruginosa through the multidrug active efflux process.
Pseudomonas aeruginosa shows significant degrees of intrinsic resistance to a wide variety of antimicrobial agents, including most ␤-lactams, tetracyclines, chloramphenicol, and fluoroquinolones. Although the outer membrane of this species has a very low nonspecific permeability to small, hydrophilic molecules (1, 26) , this alone is insufficient to explain the degree of resistance observed (16) , and an additional resistance mechanism must be postulated. With some ␤-lactams, hydrolysis of the drugs by the periplasmic ␤-lactamase can serve as this additional mechanism (see reference 18 for a discussion of this phenomenon in Escherichia coli). For other compounds that are not inactivated by wild-type cells, their active efflux out of the cell may be the most likely second contributing factor to resistance (17) . Recently, a putative operon, mexA-mexB-oprK, which codes for the export of a siderophore, pyoverdine (20) , was suggested to function also as a multidrug efflux pump because overexpression of this operon increased the resistance of P. aeruginosa to chloramphenicol, tetracycline, nalidixic acid, ciprofloxacin, and streptonigrin, and disruption of these genes made the mutants hypersusceptible to these agents (21) . (The outer membrane component of this system, previously thought to be the OprK protein seen in the multidrug-resistant strain K385 [21] , was shown recently [5] , however, to be identical to the previously described protein OprM [12] . Thus, the operon contains genes mexA, mexB, and oprM rather than oprK.) An independent study also showed that an energy-dependent efflux process decreased the steady-state accumulation levels of tetracycline, chloramphenicol, and norfloxacin in P. aeruginosa and that the efflux activity was increased in resistant clinical isolates as well as in certain laboratory mutants, although the genes involved in the efflux process were not identified (7) . In the present study, we show, by the direct assay of drug accumulation, that MexA-MexB-OprM indeed pumps out various antibacterial agents in an energy-dependent manner. (Table 1) are derivatives of strain PAO1 and have been described earlier (7, 20, 21) . HN854 and HN856 were made by transferring pPV22 (21), containing oprM::⍀Hg r , from E. coli S17-1 into a spontaneous streptomycin-resistant (rpsL) derivative of PAO4098E, HN853 (7) . Since this plasmid cannot replicate in P. aeruginosa, only the transconjugants whose oprM gene was replaced by the oprM::⍀Hg r allele through homologous recombination are selected by HgCl 2 . The transfer was carried out as described previously (21) , except that the selection for the recombinants was carried out with Luria-Bertani plates (7) containing 1 mg of streptomycin sulfate per ml and 20 g of HgCl 2 per ml.
MATERIALS AND METHODS

Antibiotics
The strains were grown either in glucose-M63 minimal medium supplemented with 0.1% Difco Casamino Acids, in Luria-Bertani broth, or in iron-deficient succinate minimal medium supplemented with 1 mM methionine (20) , with shaking at 37ЊC. Harvesting and washing were both performed by centrifugation at room temperature or at 37ЊC, in order to avoid the autolysis often induced by the chilling of P. aeruginosa cells.
MICs. MICs were determined by twofold serial broth dilution in Luria-Bertani medium or, where indicated, in iron-deficient minimal medium (20) . The inoculum was 5 ϫ 10 4 cells per tube, and the results were read after an overnight incubation at 37ЊC.
Assay of drug accumulation in intact cells. The entry of radioactive drugs into P. aeruginosa cells was measured as described previously (7) . Briefly, cells were grown in M63 minimal medium supplemented with glucose (0.2%) and Difco Casamino Acids (0.1%), harvested in the mid-exponential phase, washed, and resuspended in a buffer containing 50 mM potassium phosphate (pH 7.0), 1 mM MgSO 4 , and 0.2% glucose. At intervals after the addition of the radioactive drug, the cells were recovered by centrifugation through silicone-oil, and the drug accumulation was quantitated by liquid scintillation counting (7) . At the times indicated in Fig. 2 , a proton conductor, carbonyl cyanide m-chlorophenylhydrazone (CCCP), was added to portions of the suspensions in order to see the effect of membrane deenergization on drug accumulation. The accumulation of [ 3 H]benzylpenicillin was tested by using cells that had been pretreated for 5 min with 0.1 mM aztreonam, in order to inhibit the low, but significant, uninduced levels of endogenous ␤-lactamase (8) .
RESULTS
Identification of PAO4098E as a MexAB-OprM overproducer. As described in the introduction, it was recently found that the outer membrane protein gene in the mexAB operon was oprM rather than oprK. This means that strain K385, originally thought (21) to be overproducing MexAB and OprK, overproduces another set of putative efflux transporters, rather than MexAB, in addition to OprK. In contrast, a single-step multidrug-resistant mutant of the PAO1 line, PAO4098E, overproduced an outer membrane protein that was indistinguishable from OprM in its mobility in sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) (7) . Since the outer membrane proteins overproduced in multidrug-resistant strains are sometimes difficult to distinguish by SDS-PAGE (13), we introduced an oprM::⍀Hg r allele on a suicide vector so that it would recombine with the homologous oprM gene on the chromosome (see Materials and Methods). When the outer membrane protein patterns of two independently isolated HgCl 2 -and streptomycin-resistant transconjugants were analyzed by SDS-PAGE, the overproduced 50-kDa protein that was present in the parent strain was completely absent (Fig. 1) , showing that PAO4098E was an overproducer of OprM and therefore probably also of the proteins coded for by genes in the same operon, MexA and MexB. The disruption of the oprM gene also decreased the MIC of carbenicillin from 1,024 g/ml (in HN853) to Յ1.6 g/ml (in HN854 and HN856), as expected from the results of Gotoh et al. (4) and from the data described below.
MIC. The upper part of Table 2 shows the MICs of non-␤-lactam antibiotics and therapeutic agents for gene disruption mutants K590 and K613. Since we now know that PAO4098E is an overproducer of MexAB-OprM as described above, the MICs for this strain as well as its immediate parent PAO4098 are also listed for comparison, although many of these data have already been published in a different context (7) . In general, the results confirm the earlier observation (21) that disruption of the mexA or oprM gene makes the mutants hypersusceptible to various agents. The disruption of mexA generally had an effect very similar to that of the disruption of oprM, suggesting that elimination of any component of this presumed three-protein efflux machinery totally abolishes efflux. However, in the case of norfloxacin, the effect of oprM disruption was greater than that of mexA disruption. Possible explanations are presented in Discussion.
Comparison of PAO4098E with its parent, PAO4098, also shows that the overexpression of the system makes the organism more resistant to the agents surveyed. The MICs of fluoroquinolones for PAO4098, however, were often significantly different from those for the other wild-type PAO-derived strain, K372. Since P. aeruginosa appears to contain at least three different multidrug efflux systems (13) , this suggests that the baseline expression levels of these pumps are likely to be different for different strains, presumably as a result of inadvertently introduced, undocumented mutations. Possibly the efflux of fluoroquinolones is especially affected by these other systems. Alternatively, K372 may contain a so-far-undetected mutation in the DNA gyrase genes.
Previous studies did not address the issue of the susceptibility to ␤-lactam antibiotics of mexA-mexB-oprM disruption mutants. As shown in the lower part of Table 2 , mexA and oprM null mutants showed a noticeable increase in susceptibility to a variety of ␤-lactam antibiotics, including the newer cephalosporins, consistent with a role for the MexA-MexB-OprM pump in ␤-lactam efflux and resistance. There was no significant change in the MIC of imipenem; this may be due to the (10) . For ␤-lactams, it may be related also to differences in the induction of the chromosomally coded ␤-lactamase, as this is a complex process involving the transport of peptidoglycan fragments (6) that are likely to be affected by the nature of the medium. As reported earlier (7), the overproduction of MexAB-OprM makes the strain significantly more resistant to a number of ␤-lactams. Accumulation of tetracycline. As shown in Fig. 2A , in the parent strain K372, the steady-state accumulation level of tetracycline, 130 pmol/mg of protein, was much lower than the level of 300 pmol/mg of protein observed previously in a mutant strain with little efflux activity, K799/61 (7). This suggests the presence of energy-dependent efflux, and indeed, deenergization with CCCP increased the accumulation level, presumably by inhibiting the efflux. In the oprM null mutant K613, the accumulation level was already around 300 pmol/mg of protein even before the addition of CCCP, and this suggests that little tetracycline is pumped out in the absence of the MexA-MexBOprM machinery. (The mexA mutant K590 could not be tested because it contained a tet determinant that codes for tetracycline efflux.) The steady-state accumulation level was lower in the MexAB-OprM overproduction mutant PAO4098E than in its immediate parent, PAO4098 (see Fig. 4 of reference 7) .
Efflux of chloramphenicol. Chloramphenicol accumulation in the K372 parent strain attained a steady-state level of about 30 pmol/mg of protein (Fig. 2B) , a level which is much lower than the 90 to 100 pmol/mg of protein seen in the effluxdeficient mutant K799/61 (7). This suggests again the significant contribution of an active efflux process, and indeed, the addition of CCCP increased the accumulation to the expected level of 80 pmol/mg of protein (Fig. 2B) . The oprM mutant K613 and the mexA mutant K590, however, showed accumulation levels that were not much different from the level observed in K372 (Fig. 2B) . This result may be related to the facts that the total accumulation level is not a very sensitive indicator of the efflux rates (see Discussion) and that the difference in MICs for the null mutants and K372 was rather small (only about fourfold). In any case, the result suggests that chloramphenicol, unlike tetracycline, is still pumped out at significant rates in mutants lacking the MexAB-OprM system. Indeed, we have been able to isolate chloramphenicol-hypersusceptible mutants from K613, which presumably lack the second chloramphenicol efflux pump that is active in K613 or K590 (6a).
In contrast, there was a reproducible difference in the steady-state accumulation level of chloramphenicol between the MexAB-OprM overproduction mutant PAO4098E and its parent, PAO4098 (Fig. 3) . In the experiment shown, the chloramphenicol concentration used was much lower (0.15 M) than usual (5 M for the example in Fig. 2B ), but similar differences were seen at concentrations of 5 and 25 M (data not shown).
Accumulation of norfloxacin. The oprM mutant appeared to accumulate more drug than the K372 parent strain, although there was little difference betwen K372 and the mexA mutant (Fig. 2C) . This is consistent with the MIC data, as the oprM mutant was much more susceptible than the mexA mutant ( Table 2 ). Possible interpretations of these results are presented in Discussion. Although not shown in Fig. 2C , the addition of CCCP at 10 min to portions of cell suspensions uniformly resulted in an increase of accumulation, to 1,400 to 1,500 pmol/mg of protein, in all of the strains.
Accumulation of benzylpenicillin. Our previous study suggested that certain ␤-lactam compounds may also be actively pumped out by P. aeruginosa cells (8) . We therefore measured the accumulation of [ H]benzylpenicillin by using a previously described procedure (8) . The mexA and oprM null mutants, which were much more susceptible to ␤-lactams (Table 2) , accumulated more of the labeled compound than did K372 (Fig. 2D) , indicating an MexA-MexB-OprM-dependent efflux activity in K372. Indeed, the addition of CCCP caused a strong increase in accumulation in K372 (Fig. 2D) , supporting the presence of a strong efflux activity in nontreated cells. Interestingly, the accumulation level observed in mexA and oprM mutants was also increased by the addition of CCCP, suggesting that there is still some residual efflux activity in mutants deficient in the MexA-MexB-OprM pump.
Our previous study showed that a substantial fraction of 3 H label inside the cells is in the form of penicilloic acid, the product of hydrolysis of penicillin (8) . Most of the label outside the cell is still in the form of benzylpenicillin, however, so there should be a constant influx of benzylpenicillin from the medium. It is thus uncertain whether the assay is measuring the efflux activity for penicilloic acid, benzylpenicillin, or both, but the results nevertheless show a real difference in the drug efflux activity between the null mutants and the wild type.
DISCUSSION
Earlier work has resulted in the cloning and sequencing of the putative operon mexA-mexB-oprM from P. aeruginosa (20, 21) . MexA-MexB appears to belong to a family of gram-negative export machineries (reviewed in reference 11), such as AcrA-AcrB (previously called AcrA-AcrE), AcrE-AcrF (previously called EnvC-EnvD), MtrA-MtrB, CzcB-CzcA, CnrBCnrA, and NolF-NolGHI, in which the component listed second is a putative 12-transmembrane-segment efflux pump belonging to the RND (resistance-nodulation-division) family (24) and the component listed first belongs to the MFP (membrane-fusion protein) family, which is thought to connect the pump directly to an outer membrane channel (2). The outer membrane protein was called OprK, on the basis of the behavior of the overproduced outer membrane protein in strain K385 (21) . However, a recent study (5) of the product of the cloned ''oprK'' gene showed its identity with OprM, which was earlier shown (12) to be overproduced in nalB mutants of P. aeruginosa (23) . The operon is therefore renamed mexABoprM. The OprM protein presumably serves as the outer membrane channel component in the assembly that functions to pump out solute molecules directly into the medium, circum-FIG. 2. Accumulation of various drugs in the parental strain K372 (F) and E), the mexA insertion mutant K590 (ç and É), and the oprM insertion mutant K613 (s and ᮀ). The cells were grown in M63 medium supplemented with 0.1% Casamino Acids with glucose as the carbon source, harvested, washed, and resuspended in a phosphate buffer containing glucose, as described in Materials and Methods. After 5 min at 37ЊC, radiolabeled drugs were added, and the cellular accumulation was determined by centrifugation of cells through a silicone-oil mixture. At 10 min, CCCP (0.1 or 0. venting the outer membrane barrier. This notion is also consistent with the recent report that oprM insertion mutants are hypersusceptible to a wide variety of antibiotics (4) . For E. coli, it was recently shown that chromosomally coded multidrug efflux pumps (including AcrAB) export drugs directly into the medium, whereas plasmid-coded pumps such as TetA pump the substrates mainly into the periplasm (25) .
Evidence also suggested strongly that the physiological function of the MexA-MexB-OprM system is to export pyoverdine, a large siderophore molecule, into the medium (20) , although it may be more generally involved in the efflux of secondary metabolites (19) . At the same time, the involvement of the system in the active efflux of antibiotics was suggested, as null mutations in mexA or oprM made the mutant P. aeruginosa strains hypersusceptible to several antibiotics (20) . The results of the present study indeed support the notion that the MexAMexB-OprM system also functions as a multidrug efflux pump, because steady-state accumulation levels of some drugs are often increased in the null mutants (Fig. 2) and often decreased in the overexpression mutant ( Fig. 3 ; see also references 7 and 8). Moreover, these results agree with previous data which sugested that efflux pumps contribute to ␤-lactam resistance in P. aeruginosa. Indeed, oprM and mexA null mutants were more susceptible to a variety of ␤-lactams and accumulated more benzylpenicillin than the parent strain expressing the MexA-MexB-OprM pump.
The drug accumulation data, however, are not always easy to interpret. A complication of one type occurs because we can only measure the sum of accumulations in various compartments of the cell, whereas usually only the accumulation of the free drug in the cytoplasm is the relevant parameter. Thus, even in the well-established case of efflux-based, R plasmidmediated resistance to tetracycline, a 245-fold increase in MIC was accompanied by only a 7-fold decrease in the cellular accumulation of tetracycline (14) . In many situations, therefore, we expect that significant changes in accumulation in the cytoplasm, and therefore in the MIC, would occur without large changes in total cellular accumulation levels, and indeed some of the cases in which we failed to detect much difference in accumulation (for example, for chloramphenicol [ Fig. 2B] ) could have belonged to this category. Second, P. aeruginosa appears to produce more than one multidrug efflux system (7, 13) . Similarly, the E. coli genome contains genes for at least four homologs of the RND-type pump MexB (11) and in addition contains efflux genes coding for pumps of different types (10, 15, 22) . The presence of more than one efflux system with overlapping specificities obviously complicates the interpretation of the accumulation data, especially since each of these systems is likely to be regulated in a distinctive manner. Differences between the mexA and oprM mutants in the efflux of (Fig. 2C ) and susceptibility to (Table 2) norfloxacin, for example, might be explained if OprM is used also by another efflux machinery, which prefers norfloxacin, but not ciprofloxacin, as the substrate. Sharing of one outer membrane channel by multiple efflux systems is known to occur in E. coli, in which the TolC channel is used by at least two, and perhaps many more, export systems (3) .
In addition to the technical problems mentioned above, there is also potential concern with regard to the expected phenotype of the null mutants. Assuming that MexA-MexBOprM forms a multisubunit complex that pumps out pyoverdine as well as drugs directly into the medium, one would expect that the steady-state accumulation levels of the drugs will increase in mutants lacking any component of the complex. This effect is caused, in its simplest interpretation, by the absence of the functional efflux apparatus. However, an alternative possibility is that the remaining subunits of the apparatus assemble and produce a highly permeable leakage pathway that increases the influx of drugs into the cytoplasm. We do not believe that this is likely because of the following reasons. (i) We showed recently that deletion of the transporter component of a similar multisubunit efflux machinery, EmrAB (9), does not alter the MICs of commonly used antibiotics in E. coli (18a) . (ii) mexA or oprK null mutants are not hypersusceptible to aminoglycosides, for example (20) , and chloramphenicol continued to be pumped out effectively in both mexA and oprM mutants (Fig. 2B) . (iii) A one-step mutant, PAO4098E (7) , is now known to overproduce MexA, MexB, and OprM (see Results), rather than MexCD-OprM. Thus, the phenotype of this overproducer strain provides a set of data complementary to that from the phenotype of the null mutants examined in this study. As shown earlier (7, 8) and also in the present study (Table 2 ; Fig. 3 ), PAO4098E was highly resistant to fluoroquinolones, ␤-lactams (except imipenem), tetracycline, and chloramphenicol and accumulated lower levels of tetracycline and chloramphenicol than the isogenic parent strain. Taken together, our data indicate that the MexAB-OprM system is intimately involved in the active efflux of various antibiotics and chemotherapeutic agents, thereby contributing significantly to the intrinsic resistance of P. aeruginosa.
